Table 5

Regression models

VariablesLinear regression models (number of health problems identified)VariablesBinary logistic regression models (likelihood that the health problems would be identified)
Model 1: phase IModel 2: phase IIModel 3: phase IModel 4: phase II
Coefficient(95% CI)Coefficient(95% CI)OR(95% CI)OR(95% CI)
GroupHealth problems
 A0.00 (ref) Hypertension1.00 (ref)1.00 (ref)
 B−0.52(−1.84 to 0.79)0.00 (ref) Diabetes3.62(1.10 to 11.95)*1.72(0.53 to 5.63)
 C0.92(−0.28 to 2.12) Glaucoma1.00(0.17 to 5.82)0.44(0.13 to 1.47)
 D−2.25(−3.64 to −0.87)**−1.34(−2.69 to 0.00) * Asthma8.18(2.14 to 31.37)**1.46(0.4 to 5.33)
Age−0.15(−0.25 to −0.05)** Thyroid nodule21.75(6.73 to 70.24)***26.01(8.07 to 83.88)***
Years of GP experience0.15(0.06 to 0.24)*** Anti-coagulation8.18(2.18 to 30.74)**5.91(2.19 to 15.93)***
Remoteness Social support6.67(2.22 to 20.05)***1.00(0.27 to 3.75)
 Major city0.00 (ref) Pulmonary embolism1.77(0.36 to 8.81)0.61(0.19 to 2.02)
 Inner regional−1.35(−2.41 to −0.29) * Colorectal cancer8.18(2.13 to 31.47)**7.74(2.68 to 22.4)***
 Outer regional2.68(0.60 to 4.76)* Anxiety28.01(8.62 to 91.00)***2.01(0.77 to 5.22)
 Remote0.88(−1.03 to 2.78)Group
Patient sessions per week−0.36(−0.58 to −0.13)** A1.00 (ref)
Patient consultation h/week B0.70(0.24 to 2.08)1.00 (ref)
 <110.00 (ref) C1.58(0.69 to 3.66)
 11–201.35(−0.17 to 2.87) D0.14(0.03 to 0.67)*0.44(0.2 to 0.99)*
 21–402.30(0.75 to 3.84)**Patient sessions per week0.79(0.63 to 0.99)*
 ≥414.29(2.18 to 6.41)***Patient consultation h/week
 <111.00 (ref)
 11–201.97(0.49 to 7.82)
 21–405.63(0.92 to 34.55)
 ≥4114.61(1.68 to 127.3)*
  • *p<0.05.

  • **p<0.01.

  • ***p<0.001.

  • GP, general practitioner.